Robert Califf

Last updated
  1. 1 2 Tavernise, Sabrina (19 September 2015). "F.D.A. Nominee Califf's Ties to Drug Makers Worry Some". New York Times. Retrieved 19 September 2015.
  2. 1 2 "Califf Wins Senate Confirmation Vote on FDA Top Spot". Medscape. February 24, 2016. Retrieved 2016-02-24.
  3. "Biden nominates Robert Califf as FDA commissioner". NBC News. 12 November 2021. Retrieved 2021-11-12.
  4. 1 2 3 4 5 6 Kroll, David (26 January 2015). "Duke's Rob Califf Named FDA Deputy Commissioner". Forbes . Retrieved 5 Feb 2015.
  5. 1 2 3 "Dr. Robert Califf named FDA Deputy Commissioner for Medical Products and Tobacco" (Press release). Food and Drug Administration. 26 January 2015. Retrieved 5 Feb 2015.
  6. 1 2 Husten, Larry (26 January 2015). "Califf To Leave Duke To Become FDA Deputy Commissioner". Forbes . Retrieved 5 Feb 2015.
  7. "Ex-FDA chief Robert Califf to help lead health policy at Google, Verily full-time". FierceBiotech. October 2019. Retrieved 2021-10-15.
  8. Califf, Robert (24 February 2009). "Robert Califf, M.D., Consultant for the ABC News OnCall+ Heart Disease Center". ABC News . Retrieved 5 February 2015.
  9. 1 2 3 4 "Duke Faculty Webpage". Archived from the original on 2015-02-06. Retrieved 2015-02-06.
  10. Massimo Calabresi (19 February 2015). "Candidate to Lead FDA Has Close Ties to Big Pharma". Time Magazine. Retrieved 30 October 2015.
  11. Elias, Jennifer (30 September 2019). "Alphabet taps former FDA commissioner to oversee health strategy and policy". CNBC. Retrieved 2023-01-19.
  12. Kolata, Gina (17 November 2014). "Study Finds Alternative to Anti-Cholesterol Drug". New York Times . Retrieved 11 February 2015.
  13. 1 2 Matthew Herper (16 September 2015). "Robert Califf Could Transform The FDA -- The Right Way". Forbes. Retrieved 30 October 2015. Califf was widely seen as too linked to industry.
  14. 1 2 Matthew Herper (26 January 2015). "Yes I do think this means Robert Califf will be the next FDA Commissioner" (blog). Forbes Pharma/Healthcare. Retrieved 29 October 2015.
  15. "Robert Califf, from Aug. 2013 to Dec. 2014". Dollars for Docs. ProPublica. n.d. Retrieved 29 October 2015. Payments: At a Glance 42 payments $52,796 payment total, Rank: 23 out of 564 doctors in this specialty and state 10 companies paid this doctor.
  16. "Executive Profile Robert M. Califf M.D". Bloomberg news. n.d. Retrieved 30 October 2015.
  17. Ndiaye, Fatou (29 October 2021). "Will Biden's FDA Be Led by a Pharma Guy?". The American Prospect. Retrieved December 24, 2021.
  18. Weixel, Nathaniel (14 December 2021). "Manchin, Sanders will oppose Biden FDA nominee Califf". The Hill. Retrieved 24 December 2021.
  19. Burton, Thomas (5 February 2015). "FDA Commissioner to Resign". Wall Street Journal . Retrieved 5 February 2015.
  20. "On the Nomination (Confirmation Robert McKinnon Califf, of South Carolina, to be Commissioner of Food and Drugs)". US Senate. Retrieved 15 March 2022.
  21. "Statement from President Joe Biden Announcing His Intention to Nominate Dr. Robert Califf for Commissioner of Food and Drugs". The White House. 12 November 2021. Retrieved 15 March 2022.
  22. Collins, Kaitlyn; Sullivan, Kate (12 November 2021). "Biden picks Dr. Rob Califf as FDA commissioner". cnn.com. Retrieved 13 November 2021.
  23. "PN1372 — Robert McKinnon Califf — Department of Health and Human Services 117th Congress (2021-2022)". US Congress. 3 January 2022. Retrieved 15 March 2022.
  24. "PN1593 — Robert McKinnon Califf — Department of Health and Human Services 117th Congress (2021-2022)". US Congress. 15 February 2022. Retrieved 15 March 2022.
  25. "On the Nomination (Confirmation: Robert McKinnon Califf, of North Carolina, to be Commissioner of Food and Drugs, Department of Health and Human Services)". US Senate. Retrieved 15 March 2022.
Robert Califf
Robert M. Califf, FDA Commissioner.jpg
Califf in 2022
22nd & 25th Commissioner of Food and Drugs
Assumed office
February 17, 2022
Political offices
Preceded by Commissioner of Food and Drugs
2016–2017
Succeeded by
Preceded by Commissioner of Food and Drugs
2022–present
Incumbent